B. Zorec

Skin electroporation for transdermal drug delivery: the influence of the order of different square wave electric pulses.

Damijan Miklavčič, Matej Reberšek, Nataša Pavšelj, 2013, International journal of pharmaceutics.

Particle properties and drug metastable solubility of simvastatin containing PVP matrix particles prepared by electrospraying technique.

Špela Zupančič, Z. Lavrič, R. Dreu, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Experimental Factors to Be Considered in Electroporation-Mediated Transdermal Diffusion Experiments.

D. Miklavčič, N. Pavselj, S. Becker, 2015, Journal of biomechanical engineering.

Active enhancement methods for intra- and transdermal drug delivery: a review.

Damijan Miklavčič, Véronique Préat, Nataša Pavšelj, 2013 .

Modeling electroporation of the non-treated and vacuum impregnated heterogeneous tissue of spinach leaves

Petr Dejmek, Damijan Miklavčič, Federico Gómez Galindo, 2015 .

Ultrasound and electric pulses for transdermal drug delivery enhancement: Ex vivo assessment of methods with in vivo oriented experimental protocols.

D. Miklavčič, N. Pavselj, B. Zorec, 2015, International journal of pharmaceutics.

Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug

N. Pavselj, Špela Zupančič, J. Kristl, 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Electroporation-Enhanced Transdermal Delivery of Patent Blue Using Green Skin Pore Device

D. Miklavčič, N. Pavselj, B. Zorec, 2016 .

Transdermal transport pathway creation: Electroporation pulse order.

Damijan Miklavčič, Nataša Pavšelj, Sid Becker, 2014, Mathematical biosciences.

The effect of pulse duration, power and energy of fractional Er:YAG laser for transdermal delivery of differently sized FITC dextrans.

D. Miklavčič, N. Pavselj, B. Zorec, 2017, International journal of pharmaceutics.

Use of not authorised stem-cell based products: The Committe for Advanced Therapies (CAT) perspective

M. Vassiliou, I. Reischl, D. Niederwieser, 2010 .